300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
China
Armenia
Czech Republic
Costa Rica
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Moldova
Botswana
Seychelles
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Slovenia
Mongolia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Yaya Capital, VC Fund

Yaya Capital

VC Fund

Yaya Capital is a Venture capital and Private equity firm.

Total investments:
8
Last investment:
Lead investor:
0%

Last updated:

Industries Yaya Capital invests in

Health CareArtificial IntelligenceMachine LearningFitnessMedical

Stages Yaya Capital invests in

Series ASeries BVenture - Series Unknown

Countries Yaya Capital invests in

BrazilUnited States

Round sizes

Series A $8.8M–$52MSeries B $30M–$175M

Round size

Series A
$8.8M–$52M
Series B
$30M–$175M

Investment Focus

Industry

  • Health Care 5 (63%)
  • Artificial Intelligence 3 (38%)
  • Machine Learning 2 (25%)
  • Fitness 1 (13%)
  • Medical 1 (13%)
See all 9 industries →

Stage

  • Series A 4 (50%)
  • Series B 2 (25%)
  • Venture - Series Unknown 1 (13%)

Country

  • Brazil 3 (38%)
  • United States 3 (38%)

Investments

CompanyDescriptionRoundLinks
ISA lab is to deliver the best solution for health and offers a humanized service. ISA is an online platform where one can select the process like examination, test, or vaccine. Then schedule and make payment online, receive ISA wherever one wants. Finally, they offer a facility to check the result online and rate their service. $30M / Series B / Oct 28, 2025
NeuralMed is a native healthcare startup that analyzes all types of unstructured data from various sources to create a single safe and reliable data matrix. It develops solutions based on proprietary algorithms that maximize the full potential of real-time medical data. Its algorithms can organize patient flow by criticality and assist doctors inidentifying pathologies and structuring reports based on the analysis of free texts and images. Its solutions are dependable and easily integrated into any system, resulting in higher user adherence. Venture - Series Unknown / Nov 16, 2022
XP Health is a health tech startup introducing a new kind of vision benefit for employees leveraging machine learning.Founded in 2019 by Antonio Moraes and James Wong, XP Health is an AI-powered vision benefits platform for employees and their families to get frames from the world’s leading designers like Tom Ford, Ray-Ban, Armani, Gucci, Coach.Its proprietary deep learning model uses facial recognition technology that recommends the best frames based on facial dimensions with 98% accuracy. The company is working with companies like Chegg, Zenefits, and Sequoia Consulting Group. $17.1M / Series A / Sep 28, 2022
ISA lab is to deliver the best solution for health and offers a humanized service. ISA is an online platform where one can select the process like examination, test, or vaccine. Then schedule and make payment online, receive ISA wherever one wants. Finally, they offer a facility to check the result online and rate their service. $17M / Series A / Aug 09, 2022
Endpoint Health is a precision immunology company that is breaking the efficacy barrier of traditional pharma's “one-size-fits-all” drug development strategy by developing precision therapies with outsized efficacy potential in autoimmune and inflammatory conditions. They’re accomplishing this by leveraging OMNAI, their proprietary AI-poweredpatient discovery platform, to identify and match high-potential therapies to the patients most likely to respond. $52M / Series A / Jun 02, 2022
Klivo is a platform that connects multidisciplinary healthcare with the help of an application. $8.8M / Series A / Mar 07, 2022
Endpoint Health is a precision immunology company that is breaking the efficacy barrier of traditional pharma's “one-size-fits-all” drug development strategy by developing precision therapies with outsized efficacy potential in autoimmune and inflammatory conditions. They’re accomplishing this by leveraging OMNAI, their proprietary AI-poweredpatient discovery platform, to identify and match high-potential therapies to the patients most likely to respond. Series A / Feb 09, 2022
Metagenomi is using the power of metagenomics and machine learning to discover novel genome editing systems. $175M / Series B / Jan 25, 2022

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
China
Armenia
Czech Republic
Costa Rica
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Moldova
Botswana
Seychelles
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Slovenia
Mongolia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Yaya Capital invest in?

Yaya Capital invests primarily in Health Care, Artificial Intelligence and Machine Learning startups, most often at Series A and Series B stage. Most of the 8 investments tracked by Shizune back companies in Brazil. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Yaya Capital invest in?

Yaya Capital typically joins rounds of $8.8M–$52M at Series A and $30M–$175M at Series B. These are whole funding-round sizes, not Yaya Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Yaya Capital took part in.

When did Yaya Capital last invest?

The most recent investment recorded for Yaya Capital closed in Oct 2025. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Yaya Capital Yaya Capital Find emails